yep I bet its all good news too.
Personally I am of the opinion that we will hear the following.
1. Maiden gold pour. Amount, rate of production and comparison with model.
2. Revised cost estimate for production
3. Revised reserve/ resource statement. Upgrade including all recent drilling.
4. Increased proven and probably gold near plant warrants upgrade ASAP within context of points 2 and 3.
Consider also the possibility that JW might want a second plant of similar size at one of the other deposits (e.g .alpha) cost of trucking between deposits might be something to consider longer term. But this is by far a lower probability than the 4 points mentioned above.
Depending on the size of the cap raising it might also require an EGM. If the shares issues exceed 15% of issued capital within a year then bingo, needs Shareholder approval.
Should we get an announcement with points 1-4 above i suspect that the SP will move up strongly on certainty and direction. Leadership will count and putting the facts out there with vision is a sign of a strong company.
GC
- Forums
- ASX - By Stock
- AAM
- Ann: Trading Halt
Ann: Trading Halt , page-47
-
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AAM (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.003(5.08%) |
Mkt cap ! $29.44M |
Open | High | Low | Value | Volume |
5.9¢ | 6.1¢ | 5.6¢ | $9.671K | 169K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26672 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 24995 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26672 | 0.056 |
2 | 157272 | 0.055 |
3 | 407562 | 0.054 |
1 | 157435 | 0.053 |
2 | 159068 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 24995 | 1 |
0.062 | 15000 | 1 |
0.065 | 94262 | 1 |
0.066 | 42833 | 2 |
0.067 | 20000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AAM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online